MAGE-A4 230–239 (HLA-A*02:01)
( GVYDGREHTV )
- Description GVYDGREHTV is a linear peptidic epitope (epitope ID95091) studied as part of Melanoma-associated antigen 4 from Homo sapiens… More
- TechData GVYDGREHTV is a linear peptidic epitope (epitope ID95091) studied as part of Melanoma-associated antigen 4 from Homo sapiens… More
- Documents GVYDGREHTV is a linear peptidic epitope (epitope ID95091) studied as part of Melanoma-associated antigen 4 from Homo sapiens… More
- References
GVYDGREHTV is a linear peptidic epitope (epitope ID95091) studied as part of Melanoma-associated antigen 4 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in MHC ligand assays
| Sequence: | GVYDGREHTV | |
| Gene: | MAGE A4 | |
| Delivery: | 1-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Melanoma-associated antigen | |
| Species: | Human | |
| Allele: | HLA-A*02:01 | |
| Application : | Flow Cytometry | |
| Indication : | Cancer | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€105.00*
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
More MAGE peptides